CVS earnings beat forecasts in first tobacco-free quarter

philly.com – 11 de Febrero de 2015 – EEUU

CVS Health Corp., the largest provider of prescription drugs in the United States, posted fourth-quarter earnings that beat analyst estimates as demand for medicine outweighed the drop in revenue from a decision to stop selling tobacco products.

Profit of $1.21 a share, excluding one-time items, was one cent more than the average of analysts' estimates compiled by Bloomberg. Sales rose 13 percent to $37.1 billion, the Woonsocket, R.I.-based company said in a statement Tuesday. Analysts had projected $36 billion on average.

Growth in prescription drug sales, driven by new health insurance available to millions of previously uninsured Americans through the Affordable Care Act, is helping the company weather the loss of tobacco revenue.

CVS stopped selling cigarettes in September, making the fourth quarter the first full financial period without any tobacco-related revenue. CVS previously generated about $2 billion annually in tobacco sales.

Publicación original:
See more at:
http://www.philly.com/philly/business/20150211_CVS_earnings_beat_forecasts_in_first_tobacco-free_quarter.html#Zwo4qJICIs2t8877.99